Dark

ALNY20260116C210
ALNY Jan 16 2026 210.00 Call (ALNY260116C00210000)
option OPRA

Inactive

Apr 7, 2025

52.90-5.704%(-3.20)14

Overview Historical

open chart

1 day

Skyline

O52.90 H52.90 L52.80 C52.90 V14 OI15

MA 50 close 0.00

MA 200 close 0.00

Headquarters

Cambridge, Massachusetts, USA

Industry

Biotechnology

Sector

Healthcare

Profile

alnylam is developing an entirely new class of innovative medicines based on a breakthrough discovery in biology known as rna interference, or rnai. with rnai technology, we have the opportunity to treat disease and impact the lives of patients in a fundamentally new way by silencing disease-causing genes upstream of today's medicines.